Secondary Logo

Institutional members access full text with Ovid®

Share this article on:

Fecal microbial transplantation: an update

Bouri, Sonia; Hart, Ailsa

Current Opinion in Clinical Nutrition & Metabolic Care: September 2018 - Volume 21 - Issue 5 - p 405–410
doi: 10.1097/MCO.0000000000000488
NUTRITION AND THE GASTROINTESTINAL TRACT: Edited by M. Isabel T.D. Correia and Alastair Forbes

Purpose of review The purpose of this article is to provide an update on recent developments in fecal microbiota transplantation (FMT) in the last year.

Recent findings Although FMT is an accepted treatment for recurrent Clostridium difficile infection (CDI), recently it is also gaining acceptance for the treatment of refractory CDI. FMT is showing promise in ulcerative colitis and is experimental in many other conditions. The optimal practical aspects to enhance the success of FMT are still being established.

Summary The implication of current research is that the indications of FMT may be extended to other conditions in the future.

St Mark's Hospital, London, UK

Correspondence to Sonia Bouri, St Mark's Hospital, Watford Road, London HA1 3UJ, UK. Tel: 0208869 5808; e-mail: soniabouri@nhs.net

Copyright © 2018 Wolters Kluwer Health, Inc. All rights reserved.